Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Finally broken the 12 month high today, I wonder if this will now stay above the 74p-81p range, thoughts anyone?
AGM today, heres statement off their website Annual General Meeting Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS.L), the global medical technology company, will hold its Annual General Meeting at 11.00 today at the offices of Investec Bank plc, 2 Gresham Street, London, EC2V 7QP. AMS is trading in line with market expectations for 2013. Due to the timing of the AGM, a more detailed pre-close trading statement will be released in late June. Chris Meredith, AMS's Chief Executive Officer, will give a presentation at the Annual General Meeting, the slides from which will be made available on the Company's website www.admedsol.com. No new material information will be provided. - ends -
RNS out today, Kabouter Management increased their holding to over 3% on Friday, some US based investment company. Another positive here is the other reputable Institutions on board here, bodes well imo
Some big volume went through on Friday, thoughts anyone? AGM is on 22nd May
Another tickup today, lets hope the upward trend continues!
Another good set of results. Hopefully a push back towards the '80's. And another positive year this year will see us take a run at that elusive pound barrier. Good luck to all those invested.
Very pleased with these results following the warning issued in December about profits. Reduced debt, increased dividend, this is set up nicely going forward and the market sure likes it with the sp rise today
Adv Medical Soln Grp Final Results RNS Number : 3229Z Advanced Medical Solutions Grp PLC 06 March 2013  6 March 2013 Advanced Medical Solutions Group plc ("AMS" or the "Group") Preliminary Results for the year ended 31 December 2012 Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, today announces its unaudited preliminary results for the year ended 31 December 2012. Financial Highlights: • Group revenue up 53% to £52.6 million (2011: £34.4 million), representing growth of 57% on a constant currency basis¹ ○ Underlying like-for-like Group revenue on a constant currency basis (excluding RESORBA®) up by 3% to £35.1 million (2011: £34.4 million) • Adjusted2 operating margin up 520 bps to 24.3% (2011: 19.1%) • Adjusted2 profit before tax up 85% to £12.1 million (2011: £6.6 million) ○ Profit before tax up 135% to £10.8 million (2011: £4.6 million) • Adjusted2 fully diluted earnings per share up 24% to 5.30p (2011: 4.28p) ○ Fully diluted earnings per share up 53% to 4.66p (2011: 3.04p) • Operating cash flow before exceptional items3 of £13.4 million (2011: £6.7 million) • Net debt reduced to £5.5 million (2011: £13.4 million) ○ £3.6 million of original €25 million loan to acquire RESORBA® has been repaid ahead of schedule • Proposed final dividend of 0.35p per share, making a total dividend for the year of 0.52p (2011: 0.45p), a 16% increase compared with the prior year Business Highlights: • ActivHeal® continues its excellent progress in the NHS, with a 29% increase in revenues • Silver alginate revenues increased by 22% • RESORBA® integration completed ○ LiquiBand® sales in Germany via RESORBA® increased by 15% ○ Successful contract award to supply NHS with sutures, haemostats as well as tissue adhesives from October 2012 • In the US, LiquiBand® market share by volume increased strongly to 13% (H1 2012: 10%) in the alternate site segment, although it declined to 4% (H1 2012: 6%) in the hospital segment ○ New growth strategy launched for LiquiBand® in the US • New trilaminate foam range launched into the EU and to the NHS • Reorganisation of the Group complete to deliver growth
Results due out on 6th March
Thanks, yeah saw it was march last year so a month or so away yet, i cant make up my mind about whether to invest in this company, so might play it safe and wait for the news
Early march seems possible as last few years
Anyone know when AMS will release the full 2012 results, cant see any dates on website or previous RNS'
sell...?.....
Canaccord Genuity reiterated its "buy" recommendation on Advanced Medical Solutions (AMS) but lowered its target price by 3% to 90p. This comes on the back of a set of interim results which the broker believes were not quite as strong as they could have been, as pre-tax profits are expected to be slightly lower than the 12.5 million forecast for the full calendar year. However, the broker does acknowledge that sales of the company's Liquiband wound care product could be a source of long-term margin growth. The shares fell by 10.5p to 58.5p
Advanced Medical Solutions has a £121.69m market capitalisation
Advanced Medical Solutions has revealed its annual profits will be at the 'lower end' of market expectations. The news was unveiled Thursday in the UK-based global medical technology company's trading update which reported lower-than-expected sales of their LiquidBand product in the US market. The woundcare group said it was disappointed with its progress in the second half of 2012 after failing to sell as much they had hoped of the product, a skin adhesive for wounds. "With the gains made across a number of fronts being offset to some extent by the performance of LiquiBand in the US Acute Care hospital sector and continued pressure on foam roll-stock, overall indications for the full year are that AMS will be at the lower end of market expectation for pre-tax profits," the company said in a statement. The organisation said the overall performance of LiquiBand in the US has been mixed with success in the Alternative Site sector but trouble in targeting the larger Acute Care hospital sector. "We are actively reviewing the most effective strategy for accessing and gaining market share in this important sector. AMS's roll-stock foam revenues will also be lower than in the prior year, as previously highlighted in the interim statement," the company stated. However the company said it has made progress with ActivHeal, silver alginate and the converted foam portfolios. It is also expecting growth in existing businesses and from its Resorba brands.
Dr. Don Evans, Non-Executive Chairman of AMS, said: "We remain excited by the opportunity for LiquiBand® in the Acute Care hospital sector in the US. We are actively addressing our sales channel to achieve better market penetration as progress has been slower than expected. We have several developments coming through our R&D pipeline and these combined with further anticipated progress in our existing businesses and from our RESORBA® brands, mean that the Board remains optimistic about the Group's overall prospects." 1 The range of market expectation for profit before tax, amortisation of acquired intangible assets and exceptional items is £11.9m to £12.8m. Consensus is at £12.5m.
Pre-Close Trading Update Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS.L), the global medical technology company, today announces an update on trading prior to its close period for the year ending 31 December 2012. AMS is pleased to report that much of the progress highlighted at the Interims has continued, with ActivHeal®, silver alginate and the converted foam portfolios all showing strong year-on-year progress. The integration of RESORBA® continues to plan and the recent NHS tender awards for the Group's sutures and haemostats means the business is in a position to start delivering commercial synergies by taking these RESORBA® brands into the UK market for the first time. The overall performance of LiquiBand® in the US has, however, been mixed. LiquiBand® and LiquiBand® Flex have both continued to do well in the Alternative Site sector but, given the size of the opportunity and the quality of the Group's products, we have been disappointed with progress in the second half of 2012 in the much larger Acute Care hospital sector. We are actively reviewing the most effective strategy for accessing and gaining market share in this important sector. AMS's roll-stock foam revenues will also be lower than in the prior year, as previously highlighted in the Interim statement. With the gains made across a number of fronts being offset to some extent by the performance of LiquiBand® in the US Acute Care hospital sector and continued pressure on foam roll-stock, overall indications for the full year are that AMS will be at the lower end of market expectation1 for pre-tax profits.
I have a good contact for some very special organic cider! That and some homemade pork scratchings..
Thanks! Yes send email 2nd sept @ 16.57. Had a few questions on it, also attachments, charts. Worth a read ( not the charts) lol..
Thanks for that, i was mainly interested after i heard something about a new advance (forgive the pun) in a full coverage artificial skin that AMS are working on under the sheets so to speak. Wanting it for my usual long term play but too greedy to miss the best entry price :)
Congratulations on the pub by the way. You might end up regretting inviting me. I'm not sure you would be able to afford it. lol
Sorry mate, but i haven't got an email from you. When did you send it?
It was a triangle, so went in after it broke north.